Cell News and Research

RSS

Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’

Genomic "islands" that evolved from viruses can be converted into "drones" that disable Staphylococcus aureus, bacteria that are often resistant to antibiotics and pose a threat to safe hospital care, a new study finds.

25 Sep 2018

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.

25 Sep 2018

Clinical trial investigators found non-compliant with requirement to report results on EU register

According to EU legislation, clinical trials must be prospectively registered in the European Union Clinical Trials Register and the main results must be reported there one year after completion of the trial. This information is thus publicly available.

25 Sep 2018

Your Vision Matters: How to Protect Your Eyesight

Dr. Neil Ebenezer from the charity Fight for Sight discusses the steps you can take to protect your eyesight into old age, and why research into ophthalmic diseases is desperately needed.

24 Sep 2018

Lung cancer patients treated with invasive surgery more likely to become chronic opioid users

Patients treated with more-invasive surgical techniques for a type of early-stage lung cancer are more likely to become chronic opioid users than patients treated with minimally invasive surgery, highlighting the need for additional research into how pain management after surgery might be a contributing factor to the opioid addiction crisis, according to a study published in JAMA Oncology in September.

24 Sep 2018

Study sheds light on how brain protein may be involved neurodevelopmental disorders

A study by researchers at Rockefeller University has shown that defects in a brain protein may underlie a number of neurodevelopmental disorders.

24 Sep 2018

Gene therapy approach could help treat mitochondrial diseases

Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.

24 Sep 2018

Vanteres announces new evidence demonstrating role of LPC-DHA in fetal brain development

Vanteres, an innovative biotech company leveraging its biomedical research expertise to develop actively transported lysophospholipids, announces new evidence that demonstrates the critical role of LPC-DHA in normal fetal and infant brain development.

24 Sep 2018

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies, today announced the U.S. Food and Drug Administration has lifted the partial clinical hold that had paused U.S.-based enrollment of new patients in its tazemetostat clinical trials.

24 Sep 2018

Environmental biologist explores how songbirds stay slim despite overeating

Noticing that songbirds, such as finches, never seem to get fat despite overeating at bird feeders, London environmental biologist Lewis Halsey wondered whether the amount of energy birds put into singing, fidgeting, or exercising could be adjusted in ways that regulate weight.

24 Sep 2018

New research provides insight into the way human brain connects episodic memories to solve problems

Humans have the ability to creatively combine their memories to solve problems and draw new insights, a process that depends on memories for specific events known as episodic memory.

24 Sep 2018

Scientists discover and characterize human skeletal stem cells

Human skeletal stem cells that become bone, cartilage, or stroma cells have been isolated from fetal and adult bones. This is the first time that skeletal stem cells, which had been observed in rodent models, have been identified in humans.

24 Sep 2018

Six-year study of Hadza people reveals new insight into human cooperation

In the modern world, people cooperate with other people including strangers all the time. We give blood, tip providers of various services, and donate to charity despite the fact that there is seemingly nothing in it for us.

24 Sep 2018

Ecstasy drug makes octopuses more social

When people take MDMA, the drug popularly known as ecstasy, a rush of serotonin, dopamine, and oxytocin produces feelings of emotional closeness and euphoria, making people more interested than they would normally be in connecting and sharing with other people.

24 Sep 2018

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Harnessing the immune system to treat cancer shows great promise in some patients, but for many, the response does not last long-term.

24 Sep 2018

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.

24 Sep 2018

Columbia University announces winners of 2018 Louisa Gross Horwitz Prize

Columbia University has decided to award the Louisa Gross Horwitz Prize 2018.

24 Sep 2018

Researchers propose mechanism by which ASTN2 protein defects lead to brain disorders

In the brain, as in business, connections are everything. To maintain cellular associates, the outer surface of a neuron, its membrane, must express particular proteins--proverbial hands that reach out and greet nearby cells. And, like a creepily long handshake, surface molecules can overstay their welcome: A protein that lingers too long on the membrane may compromise the connections, or synapses, between cells.

24 Sep 2018

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.

24 Sep 2018

Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder

In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP.

24 Sep 2018

Cell News and Research

Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Clinical trial investigators found non-compliant with requirement to report results on EU register

Your Vision Matters: How to Protect Your Eyesight

Lung cancer patients treated with invasive surgery more likely to become chronic opioid users

Study sheds light on how brain protein may be involved neurodevelopmental disorders

Gene therapy approach could help treat mitochondrial diseases

Vanteres announces new evidence demonstrating role of LPC-DHA in fetal brain development

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

Environmental biologist explores how songbirds stay slim despite overeating

New research provides insight into the way human brain connects episodic memories to solve problems

Scientists discover and characterize human skeletal stem cells

Six-year study of Hadza people reveals new insight into human cooperation

Ecstasy drug makes octopuses more social

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Columbia University announces winners of 2018 Louisa Gross Horwitz Prize

Researchers propose mechanism by which ASTN2 protein defects lead to brain disorders

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder

Industry focus eBook - Cell and gene therapy (2nd edition) eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring